Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism

Summary.  Patients with acute venous thromboembolism have an increased risk for occult malignancy. Limited screening for these malignancies has become common practice but little is known about its usefulness. This is a prospective cohort follow‐up study in consecutive patients with acute venous thromboembolism. All patients underwent a routine clinical evaluation for malignancy, if negative, followed by a limited diagnostic work‐up consisting of abdominal and pelvic ultrasound and laboratory markers for malignancy. Clinical follow‐up was conducted to detect screening failures. The routine clinical evaluation was performed in 864 patients and revealed malignancy in 34 (3.9%) of them. Among the remaining 830 patients the limited diagnostic work‐up revealed 13 further malignancies. During follow‐up, cancer became symptomatic in 14 patients who were negative for cancer at screening (sensitivity of limited diagnostic work‐up, 48.1%). Malignancies that were identified by the limited diagnostic work‐up were early stage in 61% of cases vs. 14% in cases occurring during follow‐up. Most patients with occult cancer had idiopathic venous thromboembolism and were older than 70 years. A limited diagnostic work‐up for occult cancer in patients with venous thromboembolism has the capacity to identify approximately one‐half of the malignancies. Identified malignancies were predominantly in an early stage.

[1]  M. Prins,et al.  Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial , 2004, Journal of thrombosis and haemostasis : JTH.

[2]  P. Prandoni,et al.  Venous Thromboembolism as First Manifestation of Cancer , 2001, Acta Haematologica.

[3]  S. Schulman,et al.  Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. , 2000, The New England journal of medicine.

[4]  J. Olsen,et al.  [Incidence of cancer after primary deep venous thrombosis or pulmonary embolism]. , 2000, Ugeskrift for laeger.

[5]  R J Hettiarachchi,et al.  Undiagnosed malignancy in patients with deep vein thrombosis , 1998, Cancer.

[6]  J. Olsen,et al.  The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. , 1998, The New England journal of medicine.

[7]  J. Hirsh,et al.  The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study , 1998, Thrombosis and Haemostasis.

[8]  J. Emmerich,et al.  Occult cancer in patients with bilateral deep-vein thrombosis , 1997, The Lancet.

[9]  M. Monreal,et al.  Occult Cancer in Patients with Venous Thromboembolism: which Patients, which Cancers , 1997, Thrombosis and Haemostasis.

[10]  M. Prins,et al.  Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. , 1997, The New England journal of medicine.

[11]  M. Prins,et al.  Newly Diagnosed Malignancy in Patients with VenousThromboembolism. Search or Wait and See? , 1997, Thrombosis and Haemostasis.

[12]  E. Cook,et al.  Importance of Findings on the Initial Evaluation for Cancer in Patients with Symptomatic Idiopathic Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[13]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[14]  P. Bossuyt,et al.  Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. , 1996, The New England journal of medicine.

[15]  Z. Ahmed,et al.  Deep Vein Thrombosis as a Predictor of Cancer , 1996, Angiology.

[16]  E. Bastounis,et al.  The incidence of occult cancer in patients with deep venous thrombosis: a prospective study , 1996, Journal of internal medicine.

[17]  T. Kjellstrom,et al.  Deep venous thrombosis and occult malignancy: an epidemiological study , 1994, BMJ.

[18]  M. Monreal,et al.  Occult cancer in patients with acute pulmonary embolism. A prospective study. , 1993, Chest.

[19]  M. Prins,et al.  Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. , 1992, The New England journal of medicine.

[20]  Venous thromboembolism and cancer. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[21]  N. A. Sannella,et al.  “Idiopathic” deep venous thrombosis: The value of routine abdominal and pelvic computed tomographic scanning , 1991, Annals of vascular surgery.

[22]  M. Monreal,et al.  Occult cancer in patients with deep venous thrombosis. A systematic approach , 1991, Cancer.

[23]  S. String Deep venous thrombosis and pulmonary embolism: risk of subsequent malignant neoplasms: Griffin MR, Stanson AW, Brown ML, et al. Arch Intern Med 1987;147:1907–1911 , 1988 .

[24]  A A Connolly,et al.  Deep vein thrombosis. , 1988, BMJ.

[25]  M. Monreal,et al.  Cancer and deep venous thrombosis. , 1988, Archives of internal medicine.

[26]  L. Melton,et al.  Deep Venous Thrombosis and Pulmonary Embolism: Risk of Subsequent Malignant Neoplasms , 1987 .

[27]  J. Gore,et al.  Occult malignant neoplasm in patients with deep venous thrombosis. , 1987, Archives of internal medicine.

[28]  A. Zelikovski,et al.  Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer , 1986, Cancer.

[29]  J. Gore,et al.  Occult cancer in patients with acute pulmonary embolism. , 1982, Annals of internal medicine.

[30]  I. Peake International Society on Thrombosis and Haemostasis , 1974, Thrombosis and Haemostasis.